New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
Russian attackers were behind the hack of the European Medicines Agency EMA in 2020. They had “unauthorized access to ...
The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...
The European Medicines Agency said the portal will enable consultations with medical device expert panels that can promote faster access to new technologies.
Czechia proposes changes that will better define the role of patient organisations when informing patients about therapeutic procedures without violating advertising regulations.
Belgian MEP Liesbet Sommen spoke with Euractiv about critical medicines shortages, EU Pharma Package progress, and SANT's evolving role.
For investors eyeing Biocon’s stock, this approval could be a significant catalyst. According to InvestingPro’s fair value ...
South Korean biosimilars company Samsung Bioepis has announced that the US Food and Drug Administration (FDA) and European ...
Additionally, the 14-day Relative Strength Index (RSI), a key momentum indicator, falls below the 50 level, strengthening the ...
Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) and sa-mRNA pioneer Arcturus Therapeutics (Nasdaq: ARCT) today ...
The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike. Following a turbulent period marked by Brexit and the ...
Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (Nasdaq Stockholm: EGTX), today announced that the European Commission (EC) has approved Emcitate® (tiratricol) ...